These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24639833)

  • 41. Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors' Facility Residents.
    Featherstone T; Eurich DT; Simpson SH
    Value Health; 2017 Mar; 20(3):329-335. PubMed ID: 28292477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative Assessment of ADA, IDRS, and FINDRISC in Predicting Prediabetes and Diabetes Mellitus in South Indian Population.
    Doddamani P; Ramanathan N; Swetha NK; Suma MN
    J Lab Physicians; 2021 Mar; 13(1):36-43. PubMed ID: 34054237
    [No Abstract]   [Full Text] [Related]  

  • 43. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study.
    Jølle A; Midthjell K; Holmen J; Carlsen SM; Tuomilehto J; Bjørngaard JH; Åsvold BO
    BMJ Open Diabetes Res Care; 2019; 7(1):e000769. PubMed ID: 31803483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes risk assessment among squatter settlements in Pakistan: A cross-sectional study.
    Ishaque A; Shahzad F; Muhammad FH; Usman Y; Ishaque Z
    Malays Fam Physician; 2016; 11(2-3):9-15. PubMed ID: 28461852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [FINDRISC as screening for detection of prediabetes and unknown type 2 diabetes].
    Peralta HM; Costa Gil JE; Saleme AE
    Medicina (B Aires); 2024; 84(1):1-10. PubMed ID: 38271927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
    Soriguer F; Valdés S; Tapia MJ; Esteva I; Ruiz de Adana MS; Almaraz MC; Morcillo S; García Fuentes E; Rodríguez F; Rojo-Martinez G
    Med Clin (Barc); 2012 Apr; 138(9):371-6. PubMed ID: 21939990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
    BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010.
    Zhang L; Zhang Z; Zhang Y; Hu G; Chen L
    PLoS One; 2014; 9(5):e97865. PubMed ID: 24852786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FINDRISC Modified for Latin America as a Screening Tool for Persons with Impaired Glucose Metabolism in Ciudad Bolívar, Venezuela.
    Muñoz-González MC; Lima-Martínez MM; Nava A; Trerotola G; Paoli M; Cabrera-Rego JO; Gonzalez B; Arciniegas A; Paez J
    Med Princ Pract; 2019; 28(4):324-332. PubMed ID: 30852570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting type 2 diabetes mellitus among fishermen in Cape Coast: a comparison between the FINDRISC score and the metabolic syndrome.
    Ephraim RKD; Owusu VB; Asiamah J; Mills A; Abaka-Yawson A; Kpene GE; Kwadzokpui PK; Adusei S
    J Diabetes Metab Disord; 2020 Dec; 19(2):1317-1324. PubMed ID: 33520838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epicardial adipose tissue thickness and type 2 diabetes risk according to the FINDRISC modified for Latin America.
    Lima-Martínez MM; Colmenares L; Campanelli Y; Paoli M; Rodney M; Santos RD; Iacobellis G
    Clin Investig Arterioscler; 2019; 31(1):15-22. PubMed ID: 30166212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neck Circumference and its Correlation to Other Anthropometric Parameters and Finnish Diabetes Risk Score (FINDRISC).
    Volaco A; Martins CM; Soares JQ; Cavalcanti AM; Moyses ST; Filho RP; Baena CP; Precoma DB
    Curr Diabetes Rev; 2018; 14(5):464-471. PubMed ID: 28969558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
    Makrilakis K; Liatis S; Grammatikou S; Perrea D; Stathi C; Tsiligros P; Katsilambros N
    Diabetes Metab; 2011 Apr; 37(2):144-51. PubMed ID: 21144787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native Swedes.
    Bennet L; Groop L; Lindblad U; Agardh CD; Franks PW
    Prim Care Diabetes; 2014 Oct; 8(3):231-8. PubMed ID: 24472421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC).
    Väätäinen S; Cederberg H; Roine R; Keinänen-Kiukaanniemi S; Saramies J; Uusitalo H; Tuomilehto J; Martikainen J
    PLoS One; 2016; 11(2):e0147898. PubMed ID: 26840374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk-assessment score for screening diabetes mellitus among Omani adults.
    D'Souza MS; Amirtharaj A; Venkatesaperumal R; Isac C; Maroof S
    SAGE Open Med; 2013; 1():2050312113508390. PubMed ID: 26770689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study.
    Mavrogianni C; Lambrinou CP; Androutsos O; Lindström J; Kivelä J; Cardon G; Huys N; Tsochev K; Iotova V; Chakarova N; Rurik I; Moreno LA; Liatis S; Makrilakis K; Manios Y;
    Diabetes Res Clin Pract; 2019 Apr; 150():99-110. PubMed ID: 30796939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects.
    Lima-Martínez MM; Arrau C; Jerez S; Paoli M; González-Rivas JP; Nieto-Martínez R; Iacobellis G
    Prim Care Diabetes; 2017 Feb; 11(1):94-100. PubMed ID: 27914905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adults.
    Zhang Y; Hu G; Zhang L; Mayo R; Chen L
    PLoS One; 2015; 10(3):e0120382. PubMed ID: 25790106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.